Picture of Toleranzia AB logo

TOL Toleranzia AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Toleranzia Q1 Loss After Financial Items Widens To SEK 2.1 Mln

May 6 (Reuters) - Toleranzia AB  TOLE.ST :
    * Q1 NET SALES 0 SEK (0 SEK)
    * Q1 PROFIT/LOSS AFTER FINANCIAL ITEMS -2 071 922 SEK (-1
422 555
SEK)
    * DURING Q1 OF YEAR, WE HAVE CONTINUED TO DRIVE TOLERANZIA
FORWARD
IN AN EFFICIENT AND SYSTEMATIC WAY, TAKING IMPORTANT STEPS
TOWARDS FIRST CLINICAL TRIAL OF OUR LEAD DRUG CANDIDATE TOL2 IN
MYASTHENIA GRAVIS

Source text for Eikon:  ID:nMFN9cf3gf 
Further company coverage:  TOLE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Toleranzia AB

See all news